Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
09/06/2007 | US20070207180 Synthetic polypeptide-containing bioapplicable material and film-forming material |
09/06/2007 | US20070207164 Methods of using flt3-ligand in the treatment of cancer |
09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
09/06/2007 | US20070207162 Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system |
09/06/2007 | US20070207161 Immunomodulating Compositions and uses Therefor |
09/06/2007 | US20070207160 Apoptosis inhibitors |
09/06/2007 | US20070207159 Compositions and methods for enhancing antigen-specific immune response |
09/06/2007 | US20070207158 Conjugate for the specific targeting of anticancer agents to tumor cells or tumor vasculature and production thereof |
09/06/2007 | US20070207154 Method of modulating vascularization |
09/06/2007 | US20070207150 Annexin V is used to prevent thrombosis without increasing hemorrhage; annexin binds to phosphatidylserine on outer surface of cell membranes, thereby preventing binding of prothrombinase complex necessary for thrombus formation |
09/06/2007 | US20070207148 Genes associated with obesity and methods for using the same |
09/06/2007 | US20070207146 Therapeutic using a bispecific antibody |
09/06/2007 | US20070207144 Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy |
09/06/2007 | US20070207143 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
09/06/2007 | US20070207142 Compositions and methods for the treatment of tumor of hematopoietic origin |
09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
09/06/2007 | US20070207139 Enhancing the effect of therapeutic proteins on the central nervous system |
09/06/2007 | US20070207138 S/O Type Pharmaceutical Preparation and Method for Producing the Same |
09/06/2007 | US20070207137 Inhibition of Jun Kinase |
09/06/2007 | US20070207135 Drip Tray Tablet |
09/06/2007 | US20070207134 Functional food for ameliorating engogenous melatonin secretion rhythm and functional food for ameliorating circadian rhythm |
09/06/2007 | US20070207123 Amelioration of effects of cigarette smoke |
09/06/2007 | US20070207122 Compositons and methods of use of ritonavir for treating hcv |
09/06/2007 | US20070207121 Methods of Using and Compositions Comprising Selective Cytokine Inhibitory Drugs for Treatment and Management of Macular Degeneration |
09/06/2007 | US20070207120 Selective Killing Of Cancer Cells By Induction Of Acetyltransferase Via Tnf-Alpha And Il-6 |
09/06/2007 | US20070207119 synergistic; Tumor necrosis factor related apoptosis inducing ligand and LAQ824 (N-hydroxy-3-[4-[[2-hydroxyethyl-[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]prop-2-enamide) Dacinostat, which augments Apo-2L/TRAIL-induced DISC (death inducing signaling complex) and apoptosis of human acute leukemia cells |
09/06/2007 | US20070207116 Antioxidant compositions for the eye |
09/06/2007 | US20070207112 Anti-acne composition |
09/06/2007 | US20070207086 Compounds that bind to P185 and methods of using the same |
09/06/2007 | US20070206081 Ejection liquid and ejection method |
09/06/2007 | CA2580299A1 Diagnostic marker for interferon responsiveness in multiple sclerosis |
09/05/2007 | EP1830187A1 Methods of and compositions for modulating hair growth via p-cadherin modulators |
09/05/2007 | EP1829969A1 Novel polypeptide and the use thereof |
09/05/2007 | EP1829963A1 Novel shuttle vector |
09/05/2007 | EP1829892A2 Staphylococcus aureus proteins and nucleic acids |
09/05/2007 | EP1829889A2 Kahalalide f and related compounds |
09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
09/05/2007 | EP1829556A1 NK-3 Receptor in vivo assay |
09/05/2007 | EP1829552A2 Chlamydia PMP proteins, gene sequences and uses thereof |
09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
09/05/2007 | EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome |
09/05/2007 | EP1829549A1 Amorphous composition |
09/05/2007 | EP1829539A2 A method for treating tension-type headache |
09/05/2007 | EP1829533A2 Pharmaceutical formulations for dry powder inhalers |
09/05/2007 | EP1829532A1 Stable solid dosage form comprising desmopressin |
09/05/2007 | EP1829526A1 Liposome and method of injecting substance into cell by using the same |
09/05/2007 | EP1828250A2 Methods for treating autoimmune disorders |
09/05/2007 | EP1828246A1 Myd88 homodimerization inhibitors |
09/05/2007 | EP1828245A2 Igf-1 isoforms |
09/05/2007 | EP1828243A2 Growth hormone secretagogue receptor 1a ligands |
09/05/2007 | EP1828240A2 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
09/05/2007 | EP1828235A1 Exotoxin inhibitory factor |
09/05/2007 | EP1828229A1 Metabolites of cyclosporin analogs |
09/05/2007 | EP1828227A1 New peptidic and peptidoid bradykinin b1 receptor antagonists and uses thereof |
09/05/2007 | EP1828225A1 Purified rhigf-i/rhigfbp-3 complexes and their method of manufacture |
09/05/2007 | EP1828224A2 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
09/05/2007 | EP1828165A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
09/05/2007 | EP1827497A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
09/05/2007 | EP1827494A2 Combination growth therapy and cell therapy for treatment of acute and chronic diseases of the organs |
09/05/2007 | EP1827489A2 Use of flagellin in tumor immunotherapy |
09/05/2007 | EP1827486A2 Targeted use of engineered enzymes |
09/05/2007 | EP1827485A2 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation |
09/05/2007 | EP1827484A1 Augmentation of intraluminal microvessel formation to facilitate guide wire crossing in chronic total occlusions |
09/05/2007 | EP1827483A2 Therapeutic formulations of keratinocyte growth factor |
09/05/2007 | EP1827482A1 Novel uses of egf |
09/05/2007 | EP1827481A2 A composition comprising pp for the treatment of gastrointestinal disorders |
09/05/2007 | EP1827480A2 Compositions and methods for promoting wound healing and tissue regeneration |
09/05/2007 | EP1827479A1 Methods and agents useful in treating conditions characterized by mucus hyperproduction/ hypersecretion |
09/05/2007 | EP1827478A2 Methods of treatment for injured or diseased joints |
09/05/2007 | EP1827477A2 Blood pressure lowering oligopeptides in a single enzymatic step |
09/05/2007 | EP1827476A2 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
09/05/2007 | EP1827475A1 Method for treatment of hiv infection |
09/05/2007 | EP1827474A2 Heat shock proteins (hsp) and supraventricular arrhythmia |
09/05/2007 | EP1827473A2 Modulator of alpha-synuclein toxicity |
09/05/2007 | EP1827472A2 Methods for improving the structure and function of arterioles |
09/05/2007 | EP1827471A2 Composition and method for increasing apoptosis in cancer cells |
09/05/2007 | EP1827470A2 Materials and methods related to dickkopfs (dkk) and neurogenesis |
09/05/2007 | EP1827469A2 Cellular receptors utilized in the treatment of inflammatory disease |
09/05/2007 | EP1827461A1 Cladribine regimen for treating multiple sclerosis |
09/05/2007 | EP1827460A1 Nucleosides with antiviral and anticancer activity |
09/05/2007 | EP1827381A1 A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation |
09/05/2007 | EP1827366A1 Stabilized calcium phosphate complexes |
09/05/2007 | EP1827336A1 Absorbent article |
09/05/2007 | EP1827108A2 Induction of neurogenesis and stem cell therapy in combination with copolymer 1 |
09/05/2007 | EP1781682A4 B7-h5, a costimulatory polypeptide |
09/05/2007 | EP1608392A4 Papanicolau staining process |
09/05/2007 | EP1601331A4 Il-2 transmembrane constructs |
09/05/2007 | EP1576132A4 Nucleic acids and corresponding proteins entitled 273p4b7 useful in treatment and detection of cancer |
09/05/2007 | EP1570045A4 Nucleic acid and polypeptide sequences from lawsonia intracellularis and methods of using |
09/05/2007 | EP1539802B1 Novel kcnq polypeptides and their uses in the diagnosis of mental disorders |
09/05/2007 | EP1511507B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
09/05/2007 | EP1463760B1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
09/05/2007 | EP1410802B1 Cell death inducers for mast cells |
09/05/2007 | EP1267917B1 Angiogenic onchocerca volvulus proteins and uses thereof |
09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
09/05/2007 | EP1206275B1 Irrigation solution and method for inhibition of pain and inflammation |
09/05/2007 | EP1129186B1 A factor viii-polypeptide with factor viii:c-activity |
09/05/2007 | EP1113806B1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
09/05/2007 | EP1100829B1 Use of basiliximab in the treatment of rheumatoid arthritis or skin diseases |
09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |